"The CardioVascular Institute (CVI) at Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School, is the first Boston health care organization to purchase the revolutionary Veinwave™ system."
Boston, MA (PRWEB) December 8, 2009
Brian Newman, MD, FRCS, will conduct two training sessions for medical professionals on the Veinwave™ system, a revolutionary system used by doctors around the world to non-invasively eliminate spider veins and telangiectasia.
Dr. Newman, an internationally-acclaimed vascular surgeon based in the United Kingdom, developed Veinwave™ as a safe, reliable, non-invasive treatment utilizing the principle of Unipolar Thermo-Coagulation (UTC). UTC utilizes proprietary technology to deliver the unique radio-frequency energy without the need for anesthesia. An independent six-year study from Georges Pompidou Hospital documents the safety and effectiveness of this proprietary system with no side effects.
The Advanced Training Session for vascular surgeons is by invitation only and will be held Friday, Dec. 11, at the CardioVascular Institute at Beth Israel Deaconess Medical Center. A second seminar is open to all physicians and is scheduled for Saturday, Dec. 12, 9 a.m. at the Boston Marriott Newton. The seminar will cover an overview of the Veinwave™ technology, review case studies and procedural techniques, and allow attendees to observe live patient treatments. There is no fee to attend, but space is limited.
To register, contact Amy Easterly at (205) 427-9323.
The CardioVascular Institute (CVI) at Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School, is the first Boston health care organization to purchase the revolutionary Veinwave™ system. The CVI’s vascular surgeons include Allen D. Hamdan, MD, Frank B. Pomposelli, MD, Marc Schermerhorn, MD, and Mark C. Wyers, MD. Patients may book appointments by contacting the CardioVascular Institute at the Lowry Medical Office Building, 110 Francis Street, Suite 5B, Boston, MA 02215 (617) 632-9959. For more information, visit http://www.bidmc.org/vascular.
About Dr. Brian Newman, MD, FRCS
Dr. Brian Newman, MD, FRCS, is the developer of Veinwave™, a revolutionary medical device used by doctors around the world to eliminate spider veins on the legs and fine thread veins, known as telangiectasia. A General and Vascular Consultant Surgeon based in the UK, Dr. Newman graduated in medicine from Manchester University in 1968. In 1973 he became a fellow of The Royal College of Surgeons and obtained his M.D. in 1977. Dr. Newman worked as an NHS consultant general surgeon at the Royal Bolton Hospital and a number of private hospitals in the North West of England.
Since the late 1990s, Dr Newman has concentrated his work on non-invasive procedures for telangiectasia and spider veins. In July 2001, the Veinwave™ was launched in the UK. Since then, Dr. Newman has trained hundreds of surgeons and today over 1,000 systems are used every day worldwide.
The Veinwave™ is the world's most advanced treatment for effective removal of unwanted spider veins and telangiectasia. Used for nearly a decade by over 1,000 physicians in Europe, Veinwave™ recently received 510k clearance from the FDA to market in the USA. Designed primarily for vascular surgeons, dermatologists and plastic surgeons, Veinwave™ uses a revolutionary process called Unipolar Thermo-Coagulation (UTC), wherein a unique localized energy is applied to the skin on top of the affected area, causing the vein walls to collapse and the vein to disappear instantly.
Vein removal with the Veinwave™ provides safe, quick, and dramatic reduction of unwanted veins on any skin type, including ethnic and dark-skinned individuals. The technology significantly minimizes pain and the risks of bruising, burning, scaring and pigmentation changes that are associated with alternative treatments such as lasers and other light based systems. As a result, Veinwave™ has become the treatment of choice for practitioners and patients alike, providing a relatively painless walk-in/walk-out procedure with no bandages nor post-procedure care. Patients can resume regular activities and normal sun exposure immediately following treatment. For more information, visit http://www.VeinwaveUSA.com or call (205) 427-9323.